Media
Press Releases
Contact Us
Home
Our Company
Leadership Team
Board of Directors
Scientific Advisors
Partnering
Our Pipeline
Nectin-4 Biology
Integrin Biology
Publications & Presentations
Scientific Conferences
For Investors
Investor Relations
Overview
Presentations
Analyst Coverage
News / Events
Press Releases
Events
Email Alerts
Company Info
Profile
Management Team
IR Contacts
FAQ
Financial Info
Financials
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Docs
Careers
Working Here
Recruiting Scam Alert
Media
Press Releases
Contact Us
For Investors
For Investors
Overview
Presentations
Analyst Coverage
News / Events
Press Releases
Events
Email Alerts
Company Information
Profile
Management Team
IR Contacts
FAQ
Financial Information
Financials
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Board Committees
Governance Docs
Home
For Investors
Presentations
Presentations
Corporate Presentation
March 7, 2023
Partnership Project (CRB-913): an oral cannabinoid type-1 inverse agonist for obesity
